179 related articles for article (PubMed ID: 36403868)
21. Construction and validation of a novel coagulation-related 7-gene prognostic signature for gastric cancer.
Wang B; Zou D; Wang N; Wang H; Zhang T; Gao L; Ma C; Zheng P; Gu B; Li X; Wang Y; He P; Ma Y; Wang X; Chen H
Front Genet; 2022; 13():957655. PubMed ID: 36105100
[No Abstract] [Full Text] [Related]
22. N6-methyladenosine-related lncRNAs identified as potential biomarkers for predicting the overall survival of Asian gastric cancer patients.
Xu S; Chen W; Wang Y; Zhang Y; Xia R; Shen J; Gong X; Liang Y; Xu J; Tang H; Zhao T; Zhang Y; Chen T; Wang C
BMC Cancer; 2022 Jul; 22(1):721. PubMed ID: 35778697
[TBL] [Abstract][Full Text] [Related]
23. Construction of a lipid metabolism-related and immune-associated prognostic score for gastric cancer.
Dai J; Li Q; Quan J; Webb G; Liu J; Gao K
BMC Med Genomics; 2023 May; 16(1):93. PubMed ID: 37138287
[TBL] [Abstract][Full Text] [Related]
24. Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq.
Zhang D; Lu W; Cui S; Mei H; Wu X; Zhuo Z
J Ovarian Res; 2022 Nov; 15(1):123. PubMed ID: 36424614
[TBL] [Abstract][Full Text] [Related]
25. Development and Validation of a Robust Immune-Related Prognostic Signature for Gastric Cancer.
Huo J; Wu L; Zang Y
J Immunol Res; 2021; 2021():5554342. PubMed ID: 34007851
[TBL] [Abstract][Full Text] [Related]
26. Transcriptome profiling of patient-derived tumor xenografts suggests novel extracellular matrix-related signatures for gastric cancer prognosis prediction.
Deng Z; Guo T; Bi J; Wang G; Hu Y; Du H; Zhou Y; Jia S; Xing X; Ji J
J Transl Med; 2023 Sep; 21(1):638. PubMed ID: 37726803
[TBL] [Abstract][Full Text] [Related]
27. Identification of a novel immune prognostic model in gastric cancer.
Li Y; He X; Fan L; Zhang X; Xu Y; Xu X
Clin Transl Oncol; 2021 Apr; 23(4):846-855. PubMed ID: 32857339
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive Analysis Based on the Cancer Immunotherapy and Immune Activation of Gastric Cancer Patients.
Jiang F; Ma Q
Genet Res (Camb); 2023; 2023():4674536. PubMed ID: 36923953
[TBL] [Abstract][Full Text] [Related]
29. Gastric Cancer Immune Subtypes and Prognostic Modeling: Insights from Aging-Related Gene Analysis.
Shen J; Li M
Crit Rev Immunol; 2024; 44(5):1-13. PubMed ID: 38618724
[TBL] [Abstract][Full Text] [Related]
30. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
Han C; Zhang C; Wang H; Li K; Zhao L
BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
[TBL] [Abstract][Full Text] [Related]
31. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
Yang KS; Xu CQ; Lv J
Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
[TBL] [Abstract][Full Text] [Related]
32. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
Zhang X; Shi X; Zhao H; Jia X; Yang Y
Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
[TBL] [Abstract][Full Text] [Related]
33. Development and Validation of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and the Immune Microenvironment in Gastric Cancer.
Wang F; Chen C; Chen WP; Li ZL; Cheng H
Biomed Res Int; 2021; 2021():6014202. PubMed ID: 34708125
[TBL] [Abstract][Full Text] [Related]
34. A signature of six-hypoxia-related genes to evaluate the tumor immune microenvironment and predict prognosis in gastric cancer.
Zhou K; Cai C; Ding G; He Y; Hu D
BMC Med Genomics; 2022 Dec; 15(1):261. PubMed ID: 36527012
[TBL] [Abstract][Full Text] [Related]
35. An Innovative Prognostic Model Based on Four Genes in Asian Patient with Gastric Cancer.
Chen J; Wang A; Ji J; Zhou K; Bu Z; Lyu G; Ji J
Cancer Res Treat; 2021 Jan; 53(1):148-161. PubMed ID: 32878427
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive Characterization of RNA Processing Factors in Gastric Cancer Identifies a Prognostic Signature for Predicting Clinical Outcomes and Therapeutic Responses.
Lou S; Meng F; Yin X; Zhang Y; Han B; Xue Y
Front Immunol; 2021; 12():719628. PubMed ID: 34413861
[TBL] [Abstract][Full Text] [Related]
37. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
Xu HH; Wang HL; Xing TJ; Wang XQ
Front Immunol; 2022; 13():851622. PubMed ID: 35924232
[TBL] [Abstract][Full Text] [Related]
38. Drug metabolism-related eight-gene signature can predict the prognosis of gastric adenocarcinoma.
Yin HM; He Q; Chen J; Li Z; Yang W; Hu X
J Clin Lab Anal; 2021 Dec; 35(12):e24085. PubMed ID: 34773716
[TBL] [Abstract][Full Text] [Related]
39. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
[TBL] [Abstract][Full Text] [Related]
40. A Novel Ferroptosis-Related Gene Risk Signature for Predicting Prognosis and Immunotherapy Response in Gastric Cancer.
Liu SJ; Yang YB; Zhou JX; Lin YJ; Pan YL; Pan JH
Dis Markers; 2021; 2021():2385406. PubMed ID: 34868391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
